By a GenomeWeb Staff Reporter
NEW YORK (GenomeWeb News) – Sage Bionetworks today announced a deal with AstraZeneca aimed at the personalized treatment of cancer patients.
The deal, Sage said, may also lead to the development of new cancer therapeutics.
Registering provides access to this and other free content.
Already have an account?Login Now.
In Genome Research this week: multiplex genotyping of germline and somatic short tandem repeats, graph-based regularization, and more.
A lack of funding may lead more than two dozen research facilities in Australia to shut down in three months.
Researchers report that paternally inherited genes are more likely to be expressed in mice.
In PNAS this week: Akt3 amplification in glioma progression, Tibetan Plateau frog genome, and more.